25E-NBOMe explained

25E-NBOMe (2C-E-NBOMe, NBOMe-2C-E) is a derivative of the phenethylamine 2C-E. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT_2A receptor.^{[1] [2]} 25E-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

Toxicity and harm potential

Emergency treatment

Legality

Sweden

Sweden's public health agency classified 25E-NBOMe as a narcotic substance, on January 18, 2019.^[3]

See also

• 25E-NBOH (NBOH-2C-E)
• 25D-NBOMe (NBOMe-2C-D)
• 25P-NBOMe (NBOMe-2C-P)
• 25I-NBOMe (NBOMe-2C-I)
• 25B-NBOMe (NBOMe-2C-B)
• 25C-NBOMe (NBOMe-2C-C)
• 2C-TFM-NBOMe (NBOMe-2C-TFM)

Notes and References

1. Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL . Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT_2A/2C agonists . ACS Chemical Neuroscience . 5 . 3 . 243–249 . March 2014 . 24397362 . 3963123 . 10.1021/cn400216u .
2. Hansen M . Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. . Ph.D. . University of Copenhagen . 2010-12-16 . 10.13140/RG.2.2.33671.14245.
3. Web site: Sexton nya ämnen klassas som narkotika eller hälsofarlig vara . Folkhälsomyndigheten . sv . 18 January 2019 .